Hypothyroidism/subclinical hypothyroidism and metabolic dysfunction-associated steatotic liver disease: advances in mechanism and treatment

Abstract Hypothyroidism is a risk factor for metabolic dysfunction-associated steatotic liver disease (MASLD) but it is not clear whether subclinical hypothyroidism (SCH) increases the risk of MASLD and whether SCH patients with MASLD require treatment. In this study, we reviewed articles published...

Descrizione completa

Dettagli Bibliografici
Autori principali: Sicheng Pu, Binbin Zhao, Yuxuan Jiang, Xuejiao Cui
Natura: Articolo
Lingua:English
Pubblicazione: BMC 2025-02-01
Serie:Lipids in Health and Disease
Soggetti:
Accesso online:https://doi.org/10.1186/s12944-025-02474-0

Documenti analoghi